<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=9438495" created="13/06/2006" creator="Noriko Katsu"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>9438495</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Replication of <term id="T1" lex="human_immunodeficiency_virus-1" sem="Virus">human immunodeficiency virus-1</term> in <term id="T2" lex="primary_human_T_cell" sem="Cell_natural">primary human T cells</term> is dependent on the autocrine secretion of <term id="T3" lex="tumor_necrosis_factor" sem="Protein_family_or_group">tumor necrosis factor</term> through the control of <term id="T4" lex="nuclear_factor-kappa_B_activation" sem="Other"><term id="T5" lex="nuclear_factor-kappa_B" sem="Protein_complex">nuclear factor-kappa B</term> activation</term>.</sentence>
<event id="E1">
<type class="Viral_life_cycle"/>
<theme idref="T1"/>
<clue><clueType>Replication</clueType> <linkTheme>of</linkTheme> human immunodeficiency virus-1 <clueLoc>in primary human T cells</clueLoc> is dependent on the autocrine secretion of tumor necrosis factor through the control of nuclear factor-kappa B activation.</clue>
</event>
<event id="E2">
<type class="Regulation"/>
<theme idref="E1"/>
<cause idref="E4"/>
<clue>Replication of human immunodeficiency virus-1 in primary human T cells is <clueType>dependent</clueType> <linkTheme>on</linkTheme> the autocrine secretion of tumor necrosis factor <linkCause>through</linkCause> the control of nuclear factor-kappa B activation.</clue>
</event>
<event id="E3">
<type class="Localization"/>
<theme idref="T3"/>
<clue>Replication of human immunodeficiency virus-1 in primary human T cells is dependent on the <clueType>autocrine secretion</clueType> <linkTheme>of</linkTheme> tumor necrosis factor through the control of nuclear factor-kappa B activation.</clue>
</event>
<event id="E4">
<type class="Regulation"/>
<theme idref="E5"/>
<cause idref="E3"/>
<clue>Replication of human immunodeficiency virus-1 in primary human T cells is dependent on the autocrine secretion of tumor necrosis factor through the <clueType>control</clueType> <linkTheme>of</linkTheme> nuclear factor-kappa B activation.</clue>
</event>
<event id="E5">
<type class="Positive_regulation"/>
<theme idref="T5"/>
<clue>Replication of human immunodeficiency virus-1 in primary human T cells is dependent on the autocrine secretion of tumor necrosis factor through the control of nuclear factor-kappa B <clueType>activation</clueType>.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2"><term id="T6" lex="Tumor_necrosis_factor_(TNF)-alpha" sem="Protein_molecule">Tumor necrosis factor <term id="A15" sem="Protein_molecule">(TNF)-alpha</term></term> controls <term id="T7" lex="T-cell_activation" sem="Other"><term id="A4" sem="Cell_natural">T-cell</term> activation</term> and is a major inducer of <term id="T8" lex="human_immunodeficiency_virus_(HIV)-1" sem="Virus">human immunodeficiency virus (HIV)-1</term> replication in chronically infected <term id="A1" sem="Cell_natural">cells</term>.</sentence>
<event KT="Fact" id="E6">
<type class="Regulation"/>
<theme idref="E7"/>
<cause idref="A15"/>
<clue>Tumor necrosis factor (TNF)-alpha <clueType>controls</clueType> T-cell activation and is a major inducer of human immunodeficiency virus (HIV)-1 replication in chronically infected cells.</clue>
</event>
<event KT="Other" id="E7">
<type class="Physiological_process"/>
<theme idref="A4"/>
<clue>Tumor necrosis factor (TNF)-alpha controls T-cell <clueType>activation</clueType> and is a major inducer of human immunodeficiency virus (HIV)-1 replication in chronically infected cells.</clue>
</event>
<event KT="Fact" id="E8">
<type class="Positive_regulation"/>
<theme idref="E9"/>
<cause idref="T6"/>
<clue>Tumor necrosis factor (TNF)-alpha controls T-cell activation and is a major <clueType>inducer</clueType> <linkTheme>of</linkTheme> human immunodeficiency virus (HIV)-1 replication in chronically infected cells.</clue>
</event>
<event KT="Other" id="E9">
<type class="Viral_life_cycle"/>
<theme idref="T8"/>
<clue>Tumor necrosis factor (TNF)-alpha controls T-cell activation and is a major inducer of human immunodeficiency virus (HIV)-1 <clueType>replication</clueType> <clueLoc>in chronically infected cells</clueLoc>.</clue>
</event>
<event KT="Other" id="E10">
<type class="Initiation_of_viral_infection"/>
<theme idref="T8"/>
<theme idref="A1"/>
<clue>Tumor necrosis factor (TNF)-alpha controls T-cell activation and is a major inducer of human immunodeficiency virus (HIV)-1 replication in chronically <clueType>infected</clueType> cells.</clue>
</event>
<sentence id="S3">Therefore, we have investigated its role in primary cultures of <term id="A2" sem="Virus">HIV</term>-infected <term id="A3" sem="Cell_natural">human T lymphocytes</term> by using neutralizing <term id="T11" lex="anti-TNF-alpha_antibody" sem="Protein_family_or_group">anti-TNF-alpha antibodies</term> or <term id="T12" lex="TNF-alpha" sem="Protein_molecule">TNF-alpha</term>.</sentence>
<event KT="Investigation" id="E11" uncertainty="doubtful">
<type class="Regulation"/>
<cause idref="A15"/>
<clue>Therefore, we have <clueKT>investigated</clueKT> <corefCause>its</corefCause> <clueType>role</clueType> <clueLoc>in primary cultures of HIV-infected human T lymphocytes</clueLoc> by <clueExperiment>using neutralizing anti-TNF-alpha antibodies or TNF-alpha</clueExperiment>.</clue>
<comment>NO THEME</comment></event>
<event KT="Other" id="E12">
<type class="Initiation_of_viral_infection"/>
<theme idref="A2"/>
<theme idref="A3"/>
<clue>Therefore, we have investigated its role in primary cultures of HIV-<clueType>infected</clueType> human T lymphocytes by using neutralizing anti-TNF-alpha antibodies or TNF-alpha.</clue>
</event>
<sentence id="S4"><term id="A7" sem="Cell_natural">Primary resting T lymphocytes</term> produced <term id="T13" lex="TNF-alpha" sem="Protein_molecule">TNF-alpha</term> and supported <term id="T14" lex="HIV_replication" sem="Other"><term id="A6" sem="Virus">HIV</term> replication</term> after <term id="T15" lex="T-cell_receptor_activation" sem="Other"><term id="A5" sem="Protein_family_or_group">T-cell receptor</term> activation</term>.</sentence>
<event id="E13">
<type class="Gene_expression"/>
<theme idref="T13"/>
<clue>Primary <clueLoc>resting T lymphocytes</clueLoc> <clueType>produced</clueType> TNF-alpha and supported HIV replication after T-cell receptor activation.</clue>
</event>
<event id="E14">
<type class="Positive_regulation"/>
<theme idref="E15"/>
<cause idref="E16"/>
<clue>Primary resting T lymphocytes produced TNF-alpha and <clueType>supported</clueType> HIV replication <linkCause>after</linkCause> T-cell receptor activation.</clue>
</event>
<event id="E15">
<type class="Viral_life_cycle"/>
<theme idref="A6"/>
<clue>Primary resting T lymphocytes produced TNF-alpha and supported HIV <clueType>replication</clueType> after T-cell receptor activation.</clue>
</event>
<event id="E16">
<type class="Positive_regulation"/>
<theme idref="A5"/>
<cause idref="T13"/>
<clue>Primary resting T lymphocytes produced TNF-alpha and supported HIV replication after T-cell receptor <clueType>activation</clueType>.</clue>
</event>
<sentence id="S5">Addition of neutralizing <term id="T16" lex="anti-TNF-alpha_antibody" sem="Protein_family_or_group">anti-<term id="T17" lex="TNF-alpha" sem="Protein_molecule">TNF-alpha</term> antibodies</term> drastically reduced <term id="T18" lex="p24_antigen_release" sem="Other"><term id="T19" lex="p24_antigen" sem="Protein_molecule">p24 antigen</term> release</term> and prevented <term id="T20" lex="CD4+_cell_depletion" sem="Other"><term id="A9" sem="Cell_natural"><term id="T21" lex="CD4+" sem="Protein_molecule">CD4+</term> cell</term> depletion</term> associated with <term id="A8" sem="Other">infection</term>.</sentence>
<event id="E17">
<type class="Negative_regulation"/>
<theme idref="T16"/>
<theme idref="T17"/>
<clue>Addition of <clueType>neutralizing</clueType> anti-TNF-alpha antibodies drastically reduced p24 antigen release and prevented CD4+ cell depletion associated with infection.</clue>
</event>
<event id="E18">
<type class="Negative_regulation"/>
<theme idref="E19"/>
<cause idref="T16"/>
<clue>Addition of neutralizing anti-TNF-alpha antibodies drastically <clueType>reduced</clueType> p24 antigen release and prevented CD4+ cell depletion associated with infection.</clue>
</event>
<event id="E19">
<type class="Localization"/>
<theme idref="T19"/>
<clue>Addition of neutralizing anti-TNF-alpha antibodies drastically reduced p24 antigen <clueType>release</clueType> and prevented CD4+ cell depletion associated with infection.</clue>
</event>
<event id="E20">
<type class="Negative_regulation"/>
<theme idref="E21"/>
<cause idref="T16"/>
<clue>Addition of neutralizing anti-TNF-alpha antibodies drastically reduced p24 antigen release and <clueType>prevented</clueType> CD4+ cell depletion associated with infection.</clue>
</event>
<event KT="Other" id="E21">
<type class="Negative_regulation"/>
<theme idref="A9"/>
<clue>Addition of neutralizing anti-TNF-alpha antibodies drastically reduced p24 antigen release and prevented CD4+ cell <clueType>depletion</clueType> <linkCause>associated with</linkCause> infection.</clue>
</event>
<event KT="Analysis" id="E47">
<type class="Correlation"/>
<theme idref="E21"/>
<theme idref="A8"/>
<clue>Addition of neutralizing anti-TNF-alpha antibodies drastically reduced p24 antigen release and prevented CD4+ cell depletion <clueType><clueKT>associated</clueKT></clueType> <linkTheme>with</linkTheme> infection.</clue>
</event>
<sentence id="S6"><term id="T22" lex="Anti-TNF-alpha" sem="Protein_molecule">Anti-<term id="T23" lex="TNF-alpha" sem="Protein_molecule">TNF-alpha</term></term> also prevented <term id="T24" lex="nuclear_factor-kappa_B_(NF-kappa_B)_activation" sem="Other"><term id="T25" lex="nuclear_factor-kappa_B" sem="Protein_complex">nuclear factor-kappa B</term> (<term id="T26" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term>) activation</term>, and a good correlation between this inhibition and inhibition of <term id="T27" lex="HIV_replication" sem="Other"><term id="A10" sem="Virus">HIV</term> replication</term> was observed.</sentence>
<event id="E22">
<type class="Negative_regulation"/>
<theme idref="E23"/>
<cause idref="T22"/>
<clue>Anti-TNF-alpha also <clueType>prevented</clueType> nuclear factor-kappa B (NF-kappa B) activation, and a good correlation between this inhibition and inhibition of HIV replication was observed.</clue>
</event>
<event KT="Other" id="E23">
<type class="Positive_regulation"/>
<theme idref="T26"/>
<clue>Anti-TNF-alpha also prevented nuclear factor-kappa B (NF-kappa B) <clueType>activation</clueType>, and a good correlation between this inhibition and inhibition of HIV replication was observed.</clue>
</event>
<event KT="Analysis" id="E24">
<type class="Correlation"/>
<theme idref="E22"/>
<theme idref="E25"/>
<clue>Anti-TNF-alpha also prevented nuclear factor-kappa B (NF-kappa B) activation, and a good <clueType><clueKT>correlation</clueKT></clueType> <linkTheme>between</linkTheme> <corefTheme>this inhibition</corefTheme> and inhibition of HIV replication was observed.</clue>
</event>
<event KT="Other" id="E25">
<type class="Negative_regulation"/>
<theme idref="E26"/>
<cause idref="T22"/>
<clue>Anti-TNF-alpha also prevented nuclear factor-kappa B (NF-kappa B) activation, and a good correlation between this inhibition and <clueType>inhibition</clueType> <linkTheme>of</linkTheme> HIV replication was observed.</clue>
</event>
<event KT="Other" id="E26">
<type class="Viral_life_cycle"/>
<theme idref="A10"/>
<clue>Anti-TNF-alpha also prevented nuclear factor-kappa B (NF-kappa B) activation, and a good correlation between this inhibition and inhibition of HIV <clueType>replication</clueType> was observed.</clue>
</event>
<sentence id="S7">Moreover, supplementing the cultures with high doses of <term id="A13" sem="Protein_molecule">IL-2</term> reverted <term id="A12" sem="Protein_family_or_group">anti-<term id="T28" lex="TNF-alpha" sem="Protein_molecule">TNF-alpha</term></term> inhibition of <term id="A11" sem="Cell_natural">cell</term> proliferation but did not affect the inhibition of HIV <term id="T29" lex="p24_antigen_release" sem="Other"><term id="T30" lex="p24_antigen" sem="Protein_molecule">p24 antigen</term> release</term> or <term id="T31" lex="NF-kappa_B_activation" sem="Other"><term id="T32" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term> activation</term> in the same cultures.</sentence>
<event id="E27">
<type class="Negative_regulation"/>
<theme idref="E28"/>
<cause idref="A13"/>
<clue>Moreover, supplementing the cultures with high doses of IL-2 <clueType>reverted</clueType> anti-TNF-alpha inhibition of cell proliferation but did not affect the inhibition of HIV p24 antigen release or NF-kappa B activation in the same cultures.</clue>
</event>
<event KT="Other" id="E28">
<type class="Negative_regulation"/>
<theme idref="E29"/>
<cause idref="A12"/>
<clue>Moreover, supplementing the cultures with high doses of IL-2 reverted anti-TNF-alpha <clueType>inhibition</clueType> <linkTheme>of</linkTheme> cell proliferation but did not affect the inhibition of HIV p24 antigen release or NF-kappa B activation in the same cultures.</clue>
</event>
<event KT="Other" id="E29">
<type class="Cellular_physiological_process"/>
<theme idref="A11"/>
<clue>Moreover, supplementing the cultures with high doses of IL-2 reverted anti-TNF-alpha inhibition of cell <clueType>proliferation</clueType> but did not affect the inhibition of HIV p24 antigen release or NF-kappa B activation in the same cultures.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E30">
<type class="Regulation"/>
<theme idref="E32"/>
<cause idref="A13"/>
<clue>Moreover, supplementing the cultures with high doses of IL-2 reverted anti-TNF-alpha inhibition of cell proliferation but did <cluePolarity>not</cluePolarity> <clueType>affect</clueType> the inhibition of HIV p24 antigen release or NF-kappa B activation in the same cultures.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E31">
<type class="Regulation"/>
<theme idref="E33"/>
<cause idref="A13"/>
<clue>Moreover, supplementing the cultures with high doses of IL-2 reverted anti-TNF-alpha inhibition of cell proliferation but did <cluePolarity>not</cluePolarity> <clueType>affect</clueType> the inhibition of HIV p24 antigen release or NF-kappa B activation in the same cultures.</clue>
</event>
<event id="E32">
<type class="Negative_regulation"/>
<theme idref="E34"/>
<cause idref="A12"/>
<clue>Moreover, supplementing the cultures with high doses of IL-2 reverted anti-TNF-alpha inhibition of cell proliferation but did not affect the <clueType>inhibition</clueType> <linkTheme>of</linkTheme> HIV p24 antigen release or NF-kappa B activation in the same cultures.</clue>
</event>
<event id="E33">
<type class="Negative_regulation"/>
<theme idref="E35"/>
<cause idref="A12"/>
<clue>Moreover, supplementing the cultures with high doses of IL-2 reverted anti-TNF-alpha inhibition of cell proliferation but did not affect the <clueType>inhibition</clueType> <linkTheme>of</linkTheme> HIV p24 antigen release or NF-kappa B activation in the same cultures.</clue>
</event>
<event KT="Other" id="E34">
<type class="Localization"/>
<theme idref="T30"/>
<clue>Moreover, supplementing the cultures with high doses of IL-2 reverted anti-TNF-alpha inhibition of cell proliferation but did not affect the inhibition of HIV p24 antigen <clueType>release</clueType> or NF-kappa B activation <clueLoc>in the same cultures</clueLoc>.</clue>
</event>
<event KT="Other" id="E35">
<type class="Positive_regulation"/>
<theme idref="T32"/>
<clue>Moreover, supplementing the cultures with high doses of IL-2 reverted anti-TNF-alpha inhibition of cell proliferation but did not affect the inhibition of HIV p24 antigen release or NF-kappa B <clueType>activation</clueType> in the same cultures.</clue>
</event>
<sentence id="S8">Moreover, <term id="T33" lex="anti-TNF-alpha" sem="Protein_molecule">anti-<term id="T34" lex="TNF-alpha" sem="Protein_molecule">TNF-alpha</term></term> inhibited <term id="T36" lex="HIV-1_long_terminal_repeat" sem="DNA_domain_or_region"><term id="T37" lex="HIV-1" sem="Virus">HIV-1</term> long terminal repeat</term> (<term id="T38" lex="LTR" sem="DNA_domain_or_region">LTR</term>)-driven <term id="T9" sem="Other">transcription</term> of a <term id="T39" lex="reporter_gene" sem="DNA_family_or_group">reporter gene</term> in <term id="T40" lex="primary_T_cell" sem="Cell_natural">primary T cells</term> in response to activation, either in the presence or the absence of <term id="T41" lex="HIV-1_Tat" sem="Protein_molecule">HIV-1 Tat</term>.</sentence>
<event id="E36">
<type class="Negative_regulation"/>
<theme idref="E48"/>
<cause idref="T33"/>
<clue>Moreover, anti-TNF-alpha <clueType>inhibited</clueType> HIV-1 long terminal repeat (LTR)-driven transcription of a reporter gene in primary T cells in response to activation, either in the presence or the absence of HIV-1 Tat.</clue>
</event>
<event KT="Other" id="E48">
<type class="Positive_regulation"/>
<theme idref="E37"/>
<cause idref="T38"/>
<clue>Moreover, anti-TNF-alpha inhibited HIV-1 long terminal repeat (LTR)-<clueType>driven</clueType> transcription of a reporter gene in primary T cells in response to activation, either in the presence or the absence of HIV-1 Tat.</clue>
</event>
<event KT="Other" id="E37">
<type class="Transcription"/>
<theme idref="T39"/>
<clue>Moreover, anti-TNF-alpha inhibited HIV-1 long terminal repeat (LTR)-driven <clueType>transcription</clueType> <linkTheme>of</linkTheme> a reporter gene <clueLoc>in primary T cells</clueLoc> in response to activation, either in the presence or the absence of HIV-1 Tat.</clue>
</event>
<event id="E49">
<type class="Positive_regulation"/>
<theme idref="E36"/>
<cause idref="E38"/>
<clue>Moreover, anti-TNF-alpha inhibited HIV-1 long terminal repeat (LTR)-driven transcription of a reporter gene in primary T cells <linkCause>in response to</linkCause> activation, either in the presence or the absence of HIV-1 Tat.</clue>
<comment>NO CLUETYPE</comment></event>
<event id="E38">
<type class="Physiological_process"/>
<theme idref="T40"/>
<clue>Moreover, anti-TNF-alpha inhibited HIV-1 long terminal repeat (LTR)-driven transcription of a reporter gene in primary T cells in response to <clueType>activation</clueType>, either in the presence or the absence of HIV-1 Tat.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E39">
<type class="Correlation"/>
<theme idref="E36"/>
<theme idref="T41"/>
<clue>Moreover, anti-TNF-alpha inhibited HIV-1 long terminal repeat (LTR)-driven transcription of a reporter gene in primary T cells in response to activation, <linkTheme>either <cluePolarity>in the presence or the absence of</cluePolarity></linkTheme> HIV-1 Tat.</clue>
<comment>NO CLUETYPE</comment></event>
<sentence id="S9">Our results support an important role for <term id="T42" lex="autocrine_TNF-alpha_secretion" sem="Other">autocrine <term id="T43" lex="TNF-alpha" sem="Protein_molecule">TNF-alpha</term> secretion</term> in controlling <term id="T44" lex="HIV_replication" sem="Other"><term id="A14" sem="Virus">HIV</term> replication</term> in <term id="T45" lex="primary_T_cell" sem="Cell_natural">primary T cells</term> because of its ability to maintain <term id="T46" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term> elevated in the <term id="T47" lex="nucleus" sem="Cell_component">nucleus</term> of <term id="T48" lex="T_cell" sem="Cell_natural">T cells</term>.</sentence>
<event KT="Analysis" id="E41">
<type class="Regulation"/>
<theme idref="E43"/>
<cause idref="E45"/>
<clue>Our results <clueKT>support</clueKT> an important <clueType>role</clueType> for autocrine TNF-alpha secretion <linkTheme>in</linkTheme> controlling HIV replication in primary T cells <linkCause>because of</linkCause> its ability to maintain NF-kappa B elevated in the nucleus of T cells.</clue>
</event>
<event KT="Other" id="E42">
<type class="Localization"/>
<theme idref="T43"/>
<clue>Our results support an important role for <clueType>autocrine</clueType> TNF-alpha <clueType>secretion</clueType> in controlling HIV replication in primary T cells because of its ability to maintain NF-kappa B elevated in the nucleus of T cells.</clue>
</event>
<event KT="Other" id="E43">
<type class="Regulation"/>
<theme idref="E44"/>
<clue>Our results support an important role for autocrine TNF-alpha secretion in <clueType>controlling</clueType> HIV replication <clueLoc>in primary T cells</clueLoc> because of its ability to maintain NF-kappa B elevated in the nucleus of T cells.</clue>
</event>
<event KT="Other" id="E44">
<type class="Viral_life_cycle"/>
<theme idref="A14"/>
<clue>Our results support an important role for autocrine TNF-alpha secretion in controlling HIV <clueType>replication</clueType> in primary T cells because of its ability to maintain NF-kappa B elevated in the nucleus of T cells.</clue>
</event>
<event CL="L2" KT="Analysis" id="E45" uncertainty="probable">
<type class="Positive_regulation"/>
<theme idref="E46"/>
<cause idref="T43"/>
<clue>Our results support an important role for autocrine TNF-alpha secretion in controlling HIV replication in primary T cells because of <corefCause>its</corefCause> <clueKT><clueCL>ability</clueCL></clueKT> to <clueType>maintain</clueType> NF-kappa B elevated in the nucleus of T cells.</clue>
</event>
<event KT="Other" id="E46">
<type class="Positive_regulation"/>
<theme idref="T46"/>
<clue>Our results support an important role for autocrine TNF-alpha secretion in controlling HIV replication in primary T cells because of its ability to maintain NF-kappa B <clueType>elevated</clueType> <clueLoc>in the nucleus of T cells</clueLoc>.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
